South Korea Insulin Delivery Market Outlook to 2022

South Korea Insulin Delivery Market Outlook to 2022


  • Products Id :- GDMECC2101DB
  • |
  • Pages: 40
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

South Korea Insulin Delivery Market Outlook to 2022

Summary

GlobalData's new report, "South Korea Insulin Delivery Market Outlook to 2022", provides key market data on the South Korea Insulin Delivery market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

The report also provides company shares and distribution shares data for each of these market segements, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Insulin Delivery market segments-Insulin Pens, Insulin Pumps, Insulin Syringes and Traditional Insulin Pump Accessories.

Annualized market revenues (USD million) and volume (units) data for each of the market segements. Data is provided from 2008 to 2015 and forecast to 2022.

2015 company shares and distribution shares data for each of the market segements.

Global corporate-level profiles of key companies operating within the South Korea Insulin Delivery market.

Key players covered include Becton Dickinson and Co, Eli Lilly and Company, Novo Nordisk A/S and Others.

Reasons to Buy

Develop business strategies by identifying the key market segments poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 4

2 Introduction 5

2.1 What Is This Report About? 5

2.2 Insulin Delivery Market Segmentation 5

2.3 Definitions of Markets Covered in the Report 6

3 Insulin Delivery Market, South Korea 7

3.1 Insulin Delivery Market, South Korea, Revenue ($m), 2008-2015 7

3.2 Insulin Delivery Market, South Korea, Revenue ($m), 2015-2022 9

3.2.1 Insulin Pens Market, South Korea, Revenue ($m), by Segment, 2008-2015 11

3.2.2 Insulin Pumps Market, South Korea, Revenue ($m), by Segment, 2008-2015 13

3.2.3 Insulin Pens Market, South Korea, Revenue ($m), by Segment, 2015-2022 14

3.2.4 Insulin Pumps Market, South Korea, Revenue ($m), by Segment, 2015-2022 16

3.3 Insulin Delivery Market, South Korea, Volume (Units), 2008-2015 17

3.4 Insulin Delivery Market, South Korea, Volume (Units), 2015-2022 19

3.4.1 Insulin Pens Market, South Korea, Volume (Units), by Segment, 2008-2015 21

3.4.2 Insulin Pumps Market, South Korea, Volume (Units), by Segment, 2008-2015 23

3.4.3 Insulin Pens Market, South Korea, Volume (Units), by Segment, 2015-2022 24

3.4.4 Insulin Pumps Market, South Korea, Volume (Units), by Segment, 2015-2022 26

3.5 Insulin Delivery Market, South Korea, Average Price ($), 2008-2022 27

3.6 Insulin Delivery Market, South Korea, Distribution Share by Revenue ($m), 2014-2015 29

3.7 Insulin Delivery Market, South Korea, Company Share by Revenue ($m), 2015 30

4 Overview of Key Companies in South Korea, Insulin Delivery Market 32

4.1 Eli Lilly and Company 32

4.1.1 Company Overview 32

4.2 Sanofi 32

4.2.1 Company Overview 32

4.3 Becton Dickinson and Co 32

4.3.1 Company Overview 32

4.4 Novo Nordisk A/S 33

4.4.1 Company Overview 33

4.5 F. Hoffmann-La Roche Ltd 33

4.5.1 Company Overview 33

4.6 Diamesco Co Ltd 33

4.6.1 Company Overview 33

5 Insulin Delivery Market Pipeline Products 34

6 Financial Deals Landscape 35

6.1 Partnerships 35

6.1.1 Metabolon Enters into Licensing Agreement with Synlab 35

7 Appendix 36

7.1 Research Methodology 37

7.1.1 Coverage 37

7.1.2 Secondary Research 37

7.1.3 Primary Research 38

7.1.4 Company Share Analysis 38

7.1.5 Distribution Share Analysis 38

7.1.6 Benchmarking 39

7.2 GlobalData Consulting 39

7.3 Contact Us 39

7.4 Disclaimer 40

1.2 List of Figures

Figure 1: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 7

Figure 2: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 9

Figure 3: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 11

Figure 4: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 13

Figure 5: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 14

Figure 6: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 16

Figure 7: Insulin Delivery Market, South Korea, Volume (Units), Historic, 2008-2015 17

Figure 8: Insulin Delivery Market, South Korea, Volume (Units), Forecast, 2015-2022 19

Figure 9: Insulin Pens Market, South Korea, Volume (Units), Historic, 2008-2015 21

Figure 10: Insulin Pumps Market, South Korea, Volume (Units), Historic, 2008-2015 23

Figure 11: Insulin Pens Market, South Korea, Volume (Units), Forecast, 2015-2022 24

Figure 12: Insulin Pumps Market, South Korea, Volume (Units), Forecast, 2015-2022 26

Figure 13: Insulin Delivery Market, South Korea, Company Share (%) 2015 30

1.1 List of Tables

Table 1: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 8

Table 2: Insulin Delivery Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 10

Table 3: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 12

Table 4: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Historic, 2008-2015 13

Table 5: Insulin Pens Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 15

Table 6: Insulin Pumps Market, South Korea, Revenue ($m), USD Constant, Forecast, 2015-2022 16

Table 7: Insulin Delivery Market, South Korea, Volume (Units), Historic, 2008-2015 18

Table 8: Insulin Delivery Market, South Korea, Volume (Units), Forecast, 2015-2022 20

Table 9: Insulin Pens Market, South Korea, Volume (Units), Historic, 2008-2015 22

Table 10: Insulin Pumps Market, South Korea, Volume (Units), Historic, 2008-2015 23

Table 11: Insulin Pens Market, South Korea, Volume (Units), Forecast, 2015-2022 25

Table 12: Insulin Pumps Market, South Korea, Volume (Units), Forecast, 2015-2022 26

Table 13: Insulin Delivery Market, South Korea, Average Price ($) Historic, 2008-2022 27

Table 14: Insulin Delivery Market, South Korea, Average Price ($), Forecast, 2015-2022 28

Table 15: Insulin Delivery Market, South Korea, Distribution Share by Revenue ($m), USD Constant, 2014-2015 29

Table 16: Insulin Delivery Market, South Korea, Company Share by Revenue ($m), USD Constant, 2015 31

Table 17: Insulin Delivery Market Pipeline Products 34

Table 18: Metabolon Enters into Licensing Agreement with Synlab 35

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Eli Lilly and Company, Sanofi, Becton Dickinson and Co, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Diamesco Co Ltd

Diabetes Care Devices, Glucose Monitoring, Insulin Delivery, Blood Glucose Meters, Lancets, Blood Glucose Test Strips, Insulin Pens, Insulin Syringes, Insulin Pumps, Traditional Insulin Pump Accessories, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic plc, Novo Nordisk A/S, Bayer HealthCare AG, Sanofi, Eli Lilly and Company, Abbott Laboratories, Becton Dickinson and Co, Arkray Inc, Animas Corp, Insulet Corp, Nipro Corp

select a license
Single User License
USD 4995 INR 354495
Site License
USD 9990 INR 708990
Corporate User License
USD 14985 INR 1063485

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com